Merxin partners with the University of Hertfordshire for research on SMIs

Generic inhalation device developer Merxin has announced a three-year partnership with the University of Hertfordshire to further research on “the generation of fine mist and particle aerosols from formulations for deep lung delivery.” Merxin will sponsor doctoral work by UH PhD student Aurélien Martin under the supervision of Professor Darragh Murnane that will support development of Merxin’s MRX004 soft mist inhaler.

According to Merxin, Martin has previous experience as a Senior Research Assistant at UH in dry powder inhaler research, and his doctoral project will involve both SMIs and DPIs and will address the question, “How can formulations with high viscosity or low aqueous solubility be aerosolized for efficient deep lung delivery of therapies?”

The Merxin announcement concludes saying, “We wish Aurelien a lot of fun with the project and look forward to celebrating his PhD in 3 years time.”

Read the Merxin announcement.

Share

published on

Featured event:

October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden

October 21-October 22: MVIC Symposium, Lund, Sweden

October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany

November 10-November 11: Rescon Europe 2026, Porto, Portugal